MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Adctherapeutics.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Adctherapeutics.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Adctherapeutics.com most likely does not offer any adult content.
Audience
-
Bounce rate
-
Time on site
02:11
AVG
-
Gender
Men
N/A
Women
N/A
Popular pages
-
About Our Company – ADC Therapeutics
Learn about ADC Therapeutics, a commercial-stage oncology biotechnology company, leading the development of next-generation antibody drug conjugates (ADCs).
-
Antibody Drug Conjugates Clinical Development – ADC Therapeutics
Learn about the clinical development of antibody drug conjugates (ADCs) for multiple oncology indications, including Lonca (ADCT-402) and Cami (ADCT-301).
-
ADCs with Pyrrolobenzodiazepine Dimer – ADC Therapeutics
ADC Therapeutics is advancing the next generation of antibody drug conjugates (ADCs) with highly potent & targeted pyrrolobenzodiazepine (PBD) dimer technology.
-
Investors - ADC Therapeutics
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs). Learn more about investment opport...
-
ADCT-701 - ADC Therapeutics
ADCT-701 is an ADC composed of a humanized monoclonal antibody (HuBa-1-3D) directed against human DLK-1 and conjugated through a cathepsin-cleavable linker to SG3199, a PBD-dimer cytotoxin. Learn More...
-
ADC Therapeutics Innovating Science Inspiring Hope - ADC Therapeutics
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyr...